Inter-Pacific Petroleum Pte Ltd (in liquidation) v Goh Jin Hian [2024] SGHC 178

Case Details

• Citation: [2024] SGHC 178
• Court: General Division of the High Court of the Republic of Singapore
• Decision Date: 11 July 2024
• Coram: Aedit Abdullah J
• Case Number: Suit No 953 of 2020
• Hearing Date(s): 3–4 April, 2–5, 8–11 May 2023, 24 January 2024
• Claimants / Plaintiffs: Inter-Pacific Petroleum Pte Ltd (in liquidation)
• Respondent / Defendant: Goh Jin Hian
• Counsel for Claimants: Lok Vi Ming SC, Chan Kia Pheng, Chan Junhao Justin, Yong Walter, Joshua Ho Jun Ling, Ivan Khoo Yi (LVM Law Chambers LLC)
• Counsel for Respondent: Thio Shen Yi SC, Nanthini d/o Vijayakumar, Goh Enchi Jeanne, Kumar Lingesh (TSMP Law Corporation)
• Practice Areas: Companies — Directors — Duties; Duty of skill, care and diligence; Section 157(1) of the Companies Act 1967

Summary

The judgment in Inter-Pacific Petroleum Pte Ltd (in liquidation) v Goh Jin Hian [2024] SGHC 178 represents a seminal clarification of the objective standards of care, skill, and diligence expected of directors in Singapore, particularly those serving in non-executive capacities within complex trading environments. The dispute arose from the collapse of Inter-Pacific Petroleum Pte Ltd ("IPP"), a company involved in the oil and gas sector, which was found to have been used as a vehicle for massive trade financing fraud. The plaintiff, IPP (acting through its liquidators), sought to hold its former director, Dr Goh Jin Hian, liable for breaches of his statutory and common law duties. The core of the claim rested on the allegation that Dr Goh’s total failure to supervise the company’s affairs allowed fraudulent "back-to-back" cargo trading transactions to go undetected, resulting in catastrophic losses to the company and its creditors.

Aedit Abdullah J, presiding over the General Division of the High Court, delivered a robust affirmation of the principle that a director cannot abdicate their responsibilities by claiming a lack of involvement or by relying blindly on management. The court found that Dr Goh had breached his duty of care under Section 157(1) of the Companies Act 1967 and his "Creditor Duty" to consider the interests of creditors when the company was in a state of near-insolvency. The judgment is particularly significant for its detailed treatment of "red flags"—specific events that should have alerted a reasonable director to potential irregularities. These included an audit confirmation request from Mercuria Energy Trading Pte Ltd, the suspension of IPP’s Bunker Craft Operator Licence by the Maritime Port Authority of Singapore ("MPA"), and the signing of confirmations of indebtedness to Maybank without any inquiry into the underlying transactions.

Doctrinally, the case reinforces the shift away from a purely subjective standard of care. While the court acknowledged that a director’s specific knowledge and experience are relevant, it emphasized that there is an irreducible minimum standard of diligence that applies to all directors, regardless of their "non-executive" label. The court rejected Dr Goh’s defense that he was entitled to rely on the expertise of other directors and management, holding that the power to delegate does not equate to a license to ignore. Furthermore, the court applied the principles recently clarified by the Court of Appeal in Foo Kian Beng v OP3 International Pte Ltd (in liquidation) [2024] 1 SLR 361 regarding the "Creditor Duty," finding that Dr Goh’s actions in allowing IPP to draw down on bank facilities while insolvent constituted a clear breach of his duty to protect creditor interests.

The broader significance of this decision lies in its impact on corporate governance and the liability of directors in the face of corporate fraud. By ordering Dr Goh to pay US$146,047,099.60 in compensation, the High Court sent a clear signal to the Singapore business community: directors who fail to exercise reasonable diligence in monitoring their companies' affairs will be held personally liable for the resulting losses, even if they were not the primary architects of the fraud. The judgment serves as a practitioner’s guide to the limits of delegation and the necessity of proactive inquiry in the discharge of directorial duties.

Timeline of Events

1. 28 June 2011: IPP was incorporated in Singapore as a private company limited by shares. Dr Goh Jin Hian was appointed as a director upon incorporation.
2. 15 February 2012: Dr Goh was appointed as the Executive Director of IPP, a role he held for a period before transitioning to a non-executive capacity.
3. 2017–2019: IPP engaged in extensive "back-to-back" cargo trading transactions, which the liquidators later alleged were fraudulent and non-existent.
4. 31 December 2017: Date of the financial statements that showed IPP was in a precarious financial position, with significant liabilities.
5. 7 February 2018: Dr Goh received an email regarding an audit confirmation request from Mercuria Energy Trading Pte Ltd, which indicated a discrepancy in trade records.
6. 13 June 2019: The MPA informed IPP of its intention to suspend IPP’s Bunker Craft Operator Licence due to mass flow meter tampering.
7. 27 June 2019: IPP’s Bunker Craft Operator Licence was officially placed under temporary suspension by the MPA.
8. 19 July 2019: Dr Goh signed a confirmation of indebtedness to Maybank for approximately US$10.5 million without inquiring into the underlying cargo trades.
9. 12 August 2019: Dr Goh resigned from the board of directors of IPP.
10. 4 September 2019: IPP was placed under judicial management following an application by its creditors.
11. 25 March 2021: IPP was placed into compulsory liquidation by an order of the court.
12. 3 April 2023: The substantive trial of Suit No 953 of 2020 commenced before Aedit Abdullah J.
13. 11 July 2024: The High Court delivered its judgment, finding Dr Goh liable for US$146,047,099.60.

What Were the Facts of This Case?

Inter-Pacific Petroleum Pte Ltd ("IPP") was a Singapore-incorporated entity primarily engaged in two business lines: bunker trading (the supply of fuel to ships) and cargo trading (the purchase and sale of large quantities of fuel oil). The company was part of the Inter-Pacific Group, with its parent company being Inter-Pacific Group Pte Ltd ("IPG"). Dr Goh Jin Hian, the defendant, was a director of IPP from its inception on 28 June 2011 until his resignation on 12 August 2019. During his tenure, the other key directors were Cheung Lai Na ("Zoe") and Cheung Lai Ming ("Sara"), who were the daughters of the company’s founder. While Zoe and Sara were heavily involved in the day-to-day management, Dr Goh contended that his role was largely non-executive, focused on strategic oversight and business development rather than operational details.

The cargo trading business of IPP was structured around "back-to-back" transactions. In these arrangements, IPP would purchase fuel oil from a supplier and simultaneously sell it to a customer. Crucially, the delivery of the cargo was intended to occur directly from the supplier to the customer (or the customer’s order) without IPP ever taking physical possession of the fuel oil. To finance these trades, IPP relied on trade financing facilities provided by several banks, most notably Societe Generale ("SocGen") and Maybank. These facilities were typically utilized through the issuance of Letters of Credit ("LCs"). IPP would apply for an LC to pay its supplier, and the bank would pay the supplier upon presentation of shipping documents (such as Bills of Lading). IPP was then expected to repay the bank using the proceeds from its sale to the customer.

The liquidators of IPP discovered that between 2017 and 2019, a significant portion of these cargo trades were fraudulent. It was alleged that the transactions were "sham" trades where no actual cargo existed, or the documents presented to the banks were forged or falsified. This allowed IPP to draw down on millions of dollars in financing which could not be repaid because there were no genuine sales proceeds. The fraud was so extensive that by the time IPP collapsed, it owed SocGen approximately US$81.3 million and Maybank approximately US$64.7 million in relation to unpaid cargo trade financing.

The "bunker trading" side of the business also faced a crisis. In June 2019, the MPA discovered that the mass flow meter on a bunker tanker chartered by IPP had been tampered with to defraud customers of the correct quantity of fuel. This led to the suspension of IPP’s license on 27 June 2019. This event was a critical "red flag" in the litigation, as it signaled a breakdown in the company’s internal controls and integrity. Despite this, Dr Goh continued to sign bank documents, including a confirmation of indebtedness to Maybank on 19 July 2019 for US$10,508,238.71, without conducting any investigation into whether the underlying trades were genuine.

Dr Goh’s defense centered on his lack of knowledge. He argued that he was unaware of the cargo trading business, which he claimed was managed exclusively by Zoe Cheung and her team. He asserted that he was entitled to rely on the information provided by management and that he had no reason to suspect fraud until it was too late. He further argued that as a non-executive director, he was not required to be involved in the minutiae of the company’s operations. However, the liquidators pointed to several instances where Dr Goh was directly confronted with irregularities, such as the Mercuria audit confirmation in February 2018, where a counterparty denied having entered into trades that IPP’s records claimed existed. Dr Goh’s response to this—or lack thereof—formed a central part of the court’s factual inquiry.

The procedural history of the case involved IPP being placed under judicial management on 4 September 2019, shortly after Dr Goh’s resignation. The judicial managers, and later the liquidators (Mr Lim Loo Khoon and Mr Tan Wei Cheong), conducted an extensive forensic audit which revealed the depth of the insolvency and the fraudulent nature of the cargo trades. Suit No 953 of 2020 was subsequently commenced to recover the losses from Dr Goh, alleging that his negligence and breach of duty allowed the fraud to persist and the company’s liabilities to spiral out of control.

What Were the Key Legal Issues?

The determination of Dr Goh’s liability required the court to address several complex legal issues, primarily centered on the scope of directorial duties in the context of corporate insolvency and fraud. The issues can be categorized as follows:

• Breach of the Duty of Care, Skill, and Diligence: The court had to determine whether Dr Goh breached his duty under Section 157(1) of the Companies Act 1967. This involved defining the objective standard of care for a director in his position and assessing whether his failure to monitor the cargo trading business and respond to "red flags" fell below that standard. The legal hook here is the interpretation of "reasonable diligence" in the discharge of directorial duties.
• Breach of the "Creditor Duty": This issue concerned whether Dr Goh failed to take into account the interests of IPP’s creditors. Under Singapore law, as the company approaches insolvency, the directors’ duty to act in the best interests of the company shifts to include the interests of the creditors. The court had to apply the three-stage framework from Foo Kian Beng v OP3 International Pte Ltd (in liquidation) [2024] 1 SLR 361 to determine if IPP was insolvent or near-insolvent at the relevant times and whether Dr Goh’s actions (or omissions) prejudiced the creditors.
• Causation and Compensable Loss: A significant portion of the legal argument focused on whether Dr Goh’s breaches actually caused the losses claimed. Dr Goh raised several technical defenses, including the "round-tripping" theory (arguing that the money stayed within the group) and the "fraud exception" to the Quincecare duty. He argued that if the banks had no valid claim against IPP because of the fraud, then IPP suffered no loss by not paying them. The court had to decide if IPP was legally liable to the banks despite the internal fraud.
• Relief under Section 391 of the Companies Act 1967: Even if a breach was found, the court had to consider whether Dr Goh should be excused from liability because he acted "honestly and reasonably" and ought fairly to be excused. This required a subjective and objective assessment of his conduct.

Each of these issues carries significant doctrinal weight. The "duty of care" issue tests the limits of the "non-executive director" defense in modern corporate law. The "Creditor Duty" issue explores the fiduciary obligations of directors during the "twilight zone" of insolvency. The "loss" issue involves a deep dive into banking law, specifically the Quincecare duty and the autonomy of Letters of Credit, and how these intersect with a director’s liability for negligence.

How Did the Court Analyse the Issues?

The court’s analysis was exhaustive, spanning over 200 pages and meticulously addressing every defense raised by Dr Goh. The reasoning followed a structured path, beginning with the standard of care and moving through the specific instances of alleged breach.

1. The Duty of Care and the Standard of Diligence

The court began by reaffirming that the duty of care under Section 157(1) of the Companies Act 1967 is an objective one. Citing Ho Yew Kong v Sakae Holdings Ltd [2018] 2 SLR 333, Aedit Abdullah J noted that a director must exercise the degree of care that a reasonable person in the same position would exercise. The court rejected the notion that a "non-executive" director has a lower standard of diligence. While the tasks performed may differ, the duty to monitor remains constant.

"Section 157(1) of the Companies Act specifically provides that a director “shall at all times … use reasonable diligence in the discharge of the duties of his … office”, thus encapsulating a director’s common law duty of care" (at [60]).

The court emphasized that while directors can delegate functions, they cannot delegate their responsibility to supervise. Relying on Weavering Capital (UK) Ltd (in liquidation) v Peterson [2012] EWHC 1480 (Ch), the judge held that a director must maintain a "sufficient knowledge and understanding of the company’s business to enable them properly to discharge their duties" (at [135]). Dr Goh’s claim that he was "kept in the dark" about the cargo trading business was not a defense; rather, it was evidence of his failure to inquire into a major part of the company’s operations.

2. The "Red Flags" Analysis

The most damning part of the court’s analysis concerned the "red flags" that Dr Goh ignored. The court identified three critical junctures where a reasonable director would have acted:

• The Mercuria Audit Confirmation (February 2018): Mercuria had informed IPP’s auditors that they had no record of certain trades. Dr Goh was made aware of this but accepted a superficial explanation from Zoe Cheung without further investigation. The court found this to be a significant lapse, as it went to the very heart of the company’s trading integrity.
• The MPA Suspension (June 2019): The suspension of the bunker license for tampering was a "clear and present danger" to the company’s reputation and viability. The court held that this should have triggered an immediate and deep review of all company operations, including the cargo trading side, which Dr Goh failed to do.
• The Maybank Confirmations (July 2019): Despite the MPA suspension and the company’s obvious financial distress, Dr Goh signed a confirmation of indebtedness to Maybank for over US$10 million. He did so without asking for the underlying contracts or verifying if the cargo actually existed. The court characterized this as a "blind" signing that fell far below the standard of a reasonable director.

3. The Creditor Duty and Foo Kian Beng

Applying the framework from Foo Kian Beng, the court found that by at least 2018, IPP was in a state of "near-insolvency" or "impending insolvency." At this stage, Dr Goh was required to consider the interests of creditors as paramount. By allowing the company to continue drawing down on bank facilities to fund what were essentially fraudulent or non-existent trades, he prejudiced the creditors. The court noted that the "Creditor Duty" is not just about avoiding new debt, but about ensuring that the company’s remaining assets are not dissipated to the detriment of the general pool of creditors.

4. Causation, Loss, and the Quincecare Duty

Dr Goh’s most technical defense was that IPP suffered no loss because it was not legally liable to the banks. He argued that since the trades were fraudulent, the banks should have detected the fraud and refused payment under the Quincecare duty (the duty of a bank to refrain from executing an order if it has reasonable grounds to believe it is an attempt to misappropriate funds). He also invoked the "fraud exception" in Letter of Credit law.

The court systematically dismantled these arguments. First, it held that the Quincecare duty is primarily intended to protect the customer from fraud by its own agents, not to provide a shield for a negligent director. Second, the court found that the "fraud exception" to the autonomy of LCs is very narrow; a bank is only entitled to refuse payment if the fraud is "clear and obvious" to the bank at the time of presentation. In this case, the fraud was internal to IPP, and the banks were victims, not accomplices. Therefore, IPP remained liable to the banks for the drawdowns, and Dr Goh’s negligence in allowing those drawdowns caused a real, compensable loss to IPP.

"I allowed IPP’s claims against Dr Goh substantially, and held that Dr Goh was liable to pay US$146,047,099.60 in compensation to IPP in respect of his breaches of duty" (at [3]).

5. Section 391 Relief

Finally, the court refused to grant relief under Section 391. To qualify, a director must show they acted "honestly and reasonably." While the court did not find that Dr Goh was a co-conspirator in the fraud, it held that his conduct was "entirely unreasonable." His "total abdication" of responsibility meant that he could not satisfy the "reasonably" prong of the test. The court observed that granting relief in such circumstances would undermine the very purpose of directorial duties.

What Was the Outcome?

The High Court found Dr Goh Jin Hian liable for multiple breaches of his duties as a director of Inter-Pacific Petroleum Pte Ltd. The court’s primary order was for Dr Goh to pay the company compensation in the amount of US$146,047,099.60. This figure represents the principal sums owed to Societe Generale and Maybank arising from the fraudulent cargo trading transactions that occurred during the period when Dr Goh was found to be in breach of his duties.

The operative paragraph of the judgment states:

"I allowed IPP’s claims against Dr Goh substantially, and held that Dr Goh was liable to pay US$146,047,099.60 in compensation to IPP in respect of his breaches of duty" (at [3]).

In addition to the principal sum, the court addressed the issue of costs. Following the principle that costs should follow the event, the court awarded costs to IPP. Specifically, the court ordered Dr Goh to pay:

• S$332,545 in professional fees for the main suit.
• S$94,301.70 in disbursements.

The court also dealt with several interlocutory summonses (SUM 2874/2021, SUM 1925/2021, etc.), with costs for those applications also being awarded to IPP in various amounts (e.g., S$30,000 for SUM 2874/2021). The court rejected Dr Goh’s attempt to reduce the quantum of damages based on the "round-tripping" theory, finding that he had failed to provide sufficient evidence that the funds drawn from the banks had been returned to IPP or used to discharge its legitimate debts.

The judgment resulted in a total finality regarding Dr Goh’s liability at the High Court level, although the judgment mentions that the decision is subject to appeal. The outcome is a total victory for the liquidators, validating their decision to pursue the former director for the full extent of the losses suffered by the company’s creditors.

Why Does This Case Matter?

The decision in Inter-Pacific Petroleum Pte Ltd (in liquidation) v Goh Jin Hian is a landmark ruling for several reasons, primarily concerning the standard of accountability for directors in Singapore’s corporate landscape. It serves as a stark reminder that the title of "director" carries heavy legal obligations that cannot be diluted by internal arrangements or "non-executive" status.

1. The Death of the "Sleeping Director" Defense

For years, some directors in Singapore and other common law jurisdictions have operated under the assumption that if they are not involved in day-to-day management, they cannot be held responsible for operational failures or internal fraud. This case decisively shuts that door. Aedit Abdullah J’s reasoning makes it clear that every director has a "minimum and non-delegable obligation" to monitor the company’s affairs. Ignorance is not a defense; it is a breach. This will force a significant shift in how non-executive directors approach their roles, necessitating a more inquisitive and skeptical mindset.

2. Clarification of the "Red Flag" Jurisprudence

The judgment provides a detailed roadmap of what constitutes a "red flag" and how a director must respond. By analyzing the Mercuria audit and the MPA suspension, the court established that once a director is put on notice of a potential problem, they must "pull the thread" until they are satisfied that the issue is resolved. Merely accepting management’s word is insufficient. This provides practitioners with clear examples of the type of conduct that will be scrutinized in future negligence claims.

3. Intersection of Banking Law and Director Liability

The court’s rejection of the Quincecare and Letter of Credit defenses is doctrinally significant. It prevents directors from shifting the blame for their own negligence onto the company’s banks. By holding that the Quincecare duty does not protect a negligent director from a claim by his own company, the court ensured that the primary responsibility for corporate integrity remains with the board. This protects the stability of the trade financing system, as banks are not made the "insurers" of a company’s internal governance failures.

4. Application of the Creditor Duty

This is one of the first major High Court decisions to apply the Court of Appeal’s guidance in Foo Kian Beng. It demonstrates how the "Creditor Duty" operates in practice, particularly in the "twilight zone" of insolvency. The massive quantum of the award—over US$146 million—highlights the potential exposure for directors who fail to pivot their focus to creditor interests when the company is in financial distress. It underscores that the "Creditor Duty" is a powerful tool for liquidators to recover assets for the benefit of unpaid creditors.

5. Impact on the Oil and Gas/Commodities Sector

Given Singapore’s status as a global hub for oil trading, this case has particular resonance for the commodities sector. The "back-to-back" trading model is common, but this judgment highlights its inherent risks. Directors of trading firms must now ensure they have robust systems to verify the existence of cargo and the authenticity of shipping documents. The case will likely lead to more stringent internal audit requirements and a more cautious approach to trade financing.

Practice Pointers

• Non-Executive Status is No Shield: Practitioners must advise clients that the "non-executive" label does not lower the objective standard of care. A director must always supervise the discharge of delegated functions, failing which he would have breached his duty of skill, care and diligence.
• The Duty to Inquire: When presented with "red flags"—such as regulatory suspensions or audit discrepancies—directors must conduct independent inquiries. Relying solely on the explanations of executive directors or management is legally "unreasonable" if the red flag is significant.
• Signing Documents is a Substantive Act: Directors should never sign bank confirmations, LCs, or financial statements "blindly." Signing a confirmation of indebtedness without verifying the underlying trades is a breach of the duty of care.
• Monitor the "Twilight Zone": As a company approaches insolvency, the board must document its consideration of creditor interests. Practitioners should assist boards in identifying the point at which the "Creditor Duty" is triggered under the Foo Kian Beng framework.
• Delegation vs. Abdication: While delegation is permitted, the board must have a system of "supervision and control." A director who is "kept in the dark" about a major business line has likely abdicated their duty rather than delegated it.
• Section 391 Relief is a High Bar: To rely on the court’s discretion to excuse a breach, a director must prove they acted both "honestly" and "reasonably." Negligent monitoring is almost always considered "unreasonable," making this relief difficult to obtain in oversight cases.
• Verify Cargo in Back-to-Back Trades: For directors in the commodities sector, specific attention must be paid to the verification of physical cargo. The court’s analysis suggests that a failure to implement systems to check the reality of trades can lead to personal liability if fraud occurs.

Subsequent Treatment

As of the date of the judgment (11 July 2024), the decision represents the current authoritative position of the High Court on the liability of non-executive directors for oversight failures in the context of trade financing fraud. The judgment specifically incorporates and applies the Court of Appeal’s recent findings in Foo Kian Beng v OP3 International Pte Ltd (in liquidation) [2024] 1 SLR 361 regarding the "Creditor Duty." While the judgment notes that the defendant may seek an appeal, its detailed analysis of "red flags" and the rejection of the Quincecare defense as a shield for directors is expected to be frequently cited in future insolvency and director-liability litigation in Singapore.

Legislation Referenced

• Companies Act 1967 (2020 Rev Ed), Section 157(1), Section 157C, Section 391
• Insolvency, Restructuring and Dissolution Act 2018 (2020 Rev Ed), Section 239, Section 239(12)
• Evidence Act 1893 (2020 Rev Ed), Section 105

Cases Cited

• Applied: [2018] 2 SLR 333 (Ho Yew Kong v Sakae Holdings Ltd)
• Applied: [2024] 1 SLR 361 (Foo Kian Beng v OP3 International Pte Ltd (in liquidation))
• Considered: [2024] AC 211 (BTI 2014 LLC v Sequana SA)
• Referred to: [2024] SGHC 130 (Re Mingda Holding Pte Ltd)
• Referred to: [2023] SGHC 245 (Voltas Limited v Ng Theng Swee and another)
• Referred to: [2023] SGHC 127 (Hector Finance Group Ltd and another v Chan Chew Keak)
• Referred to: [2024] SGHC 105 (Park Hotel CQ Pte Ltd (in liquidation) and others v Law Ching Hung)
• Referred to: [2023] SGHC 68 (Kotagaralahalli Peddappaiah Nagaraja v Moussa Salem and others)
• Referred to: [2022] SGHC 142 (The Wave Studio Pte Ltd and others v General Hotel Management (Singapore) Pte Ltd)
• Referred to: [2002] 2 SLR(R) 848 (Lim Weng Kee v Public Prosecutor)
• Referred to: [2023] 1 SLR 1648 (BIT Baltic Investment & Trading Pte Ltd (in compulsory liquidation) v Wee See Boon)
• Referred to: [2017] 4 SLR 1153 (Abdul Ghani bin Tahir v Public Prosecutor)
• Referred to: [2004] 4 SLR(R) 162 (Vita Health Laboratories Pte Ltd and others v Pang Seng Meng)
• Referred to: [2017] 3 SLR 839 (Prima Bulkship Pte Ltd (in creditors’ voluntary liquidation) and another v Lim Say Wan and another)
• Referred to: [2010] 4 SLR 1089 (Liquidators of Progen Engineering Pte Ltd v Progen Holdings Ltd)
• Referred to: [2014] 3 SLR 277 (Dynasty Line (in liquidation) v Sukamto Sia and another)
• Referred to: [2017] 2 SLR 592 (Goh Chan Peng and others v Beyonics Technology Ltd)
• Referred to: [1994] 3 SLR(R) 1064 (Intraco Ltd v Multi-Pak Singapore Pte Ltd)
• Referred to: [2014] 3 SLR 329 (Ho Kang Peng v Scintronix Corp Ltd)
• Referred to: [2019] 3 SLR 132 (Ong Bee Chew v Ong Shu Lin)
• Referred to: [2021] 2 SLR 478 (Sembcorp Electric Power Pte Ltd v RCMA Asia Pte Ltd)
• Referred to: [2020] 1 SLR 1199 (Sim Poh Ping v Winsta Holding Pte Ltd)
• Referred to: [2019] 2 SLR 295 (Bintai Kindenko Pte Ltd v Samsung C&T Corp and another)
• Referred to: [2011] 2 SLR 63 (Raiffeisen-Borelenleenbank BA, Singapore Branch v Motorola Electronics Pte Ltd)
• Referred to: [2023] 2 SLR 587 (UniCredit Bank AG v Glencore Singapore Pte Ltd)
• Referred to: [2003] 1 SLR(R) 597 (Beam Technology (Mfg) Pte Ltd v Standard Chartered Bank)
• Referred to: [2011] 2 SLR 178 (Hsu Ann Mei (as executrix of the estate of Hwang Chen Tsu Hsu, deceased) v Oversea-Chinese Banking Corp Ltd)
• Referred to: [1996] 2 SLR(R) 774 (Yogambikai Nagarajah v Indian Overseas Bank)
• Referred to: [2024] AC 346 (Philipp v Barclays Bank UK plc)
• Referred to: [2023] AC 761 (Stanford International Bank Ltd (in liquidation) v HSBC Bank plc)

Source Documents

• Original Judgment PDF (eLitigation)
• Case Details on eLitigation